referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">

**Investors Race Against Deadline to Lead GPGI Securities Fraud Lawsuit**

*NEW YORK, Aug. 31, 2026 /PRNewswire/ — Rosen Law Firm, a global investor‑rights boutique, has issued a fresh reminder to holders of Class A common stock of GPGI, Inc. (f/k/a CompoSecure, Inc.) (NYSE: GPGI, CMPO). The firm warns that anyone who purchased shares between Nov. 3, 2025 and May 6, 2026 must act before the filing deadline to join the pending securities‑fraud action.*

---

### Introduction

The securities‑fraud case against GPGI, Inc. has entered its most time‑sensitive phase. Rosen Law Firm, renowned for representing institutional and retail investors in high‑profile corporate misconduct, has sent a formal notice urging eligible shareholders to submit their claims before the court‑imposed cut‑off date. Failure to do so could forfeit the right to recover alleged losses stemming from alleged misstatements about GPGI’s financial health and product pipeline.

### Key Developments

- **Deadline Alert:** The filing window closes on **Oct. 15, 2026**. Rosen’s notice, distributed through major financial news wires and direct email, reiterates the need for prompt action.
- **Allegations:** Plaintiffs allege that GPGI misled investors by overstating revenue from its next‑generation biometric security solutions and by concealing material operational setbacks.
- **Class Definition:** The lawsuit targets holders of **Class A common stock** purchased during the seven‑month window from **Nov. 3, 2025 to May 6, 2026**.
- **Legal Strategy:** Rosen plans to consolidate individual claims into a class‑action suit, leveraging its experience in securities litigation to maximize recovery potential.

### Industry Analysis

The GPGI controversy arrives amid a broader wave of scrutiny on technology firms that have rapidly scaled through aggressive IPO roadshows. Analysts note that the **biometric security sector** has seen a 22 % year‑over‑year increase in market capitalization, yet the pace of product commercialization often outstrips transparent reporting.

“Investors are demanding higher standards of disclosure, especially when companies tout disruptive tech that can reshape critical infrastructure,” said Maya Patel, a senior analyst at MarketWatch Research. “The GPGI case underscores the risk of over‑promising in a hot market, and it may prompt regulators to tighten reporting requirements for emerging‑tech IPOs.”

### Future Outlook

If Rosen’s class action proceeds, the litigation